CXL für Alle
Entdecken Sie die Zukunft des Cross-Linking
Für modernes CXL: passt auf Design-Spaltlampen von Haag Streit und Zeiss.
TischbefestigungFor classic CXL: table mount accessory available.
Integrierte ProtokolleWählen Sie aus einer Reihe von vorprogrammierten klinischen Protokollen.
Spektrum der IntensitätenBietet 3, 9, 15, 18 und 30 mW/cm².
Gepulstes & kontinuierliches Licht
For various keratoconus
Für verschiedene Keratokonus- und infektiöse Keratitis-Einstellungen.
Dickenangepasstes Profil
Beam profile delivers
Das Strahlprofil liefert mehr Energie in der Hornhautperipherie.
Herausragende Batterie-Technologie
Gebaut, um Tausenden von Behandlungen standzuhalten.
Rollstuhlgängig
Menschen im Rollstuhl unkompliziert behandeln
Das C-eye Gerät ist CE-zertifiziert für folgende Indikationen: Keratokonus, Ektasie nach LASIK/PRK, pelluzidale marginale Degeneration, infektiöse Keratitis, sterile Hornhauteinschmelzung, bullöse Keratopathie.
Das C-eye Gerät von EMAGine bringt die Vernetzungstechnologie an die Spaltlampe. Einfach, effizient und sicher vom Einsteiger bis zum erfahrenen Anwender.
Führen Sie CXL an der Spaltlampe durch. Oder verwenden Sie das C-eye-Gerät wie jedes andere CXL-Gerät: auf einer Tischhalterung, in Ihrem OP-Saal.
Arbeiten Sie an verschiedenen Orten? Nehmen Sie das C-eye Gerät überall hin mit. Laden Sie es über USB-C, mit Ihrem Smartphone-Ladegerät oder Ihrem Laptop auf.
Reduziert Zeit und Kosten im Zusammenhang mit der Durchführung von CXL
Das C-eye Gerät wird das Cross-Linking revolutionieren
Alle 221.000 Augenärzte sind durch ein einziges Gerät vereint: die Spaltlampe. Sie definiert unseren Beruf. Die C-eye-Technologie bietet all diesen Augenärzten die Möglichkeit, das CXL an der Spaltlampe durchzuführen. Ohne Operationssaal. Effizient. Sicher.
Kann ich CXL in meinem Büro durchführen?
Remember that every cross-linking procedure not only improves biomechanics, it also “disinfects” the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is “sterile”. And by the way: office-based cataract surgery und office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach hier.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not “care” whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon’s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see hier.
Find more answers in our FAQ section.


Das C-eye Gerät passt zu einer Reihe von Spaltlampen vom Typ Haag-Streit und Zeiss.

POSTS
High fluence PACK-CXL is better than low fluence PACK-CXL
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
Prof. Farhad Hafezi erklärt den Zusammenhang zwischen CXL und Sauerstoff
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
Digital Ophthalmology Interviews EMAGine CEO, Nikki Hafezi
Dr. Sebastian Siebelman from the media outlet, “Digital Ophthalmology” interviewed EMAGine AG’s Chief Executive Officer, Nikki Hafezi, on how she turns ideas into reality – and this includes EMAGine AG!
Landmark PACK-CXL trial published
This month, a landmark PACK-CXL trial was published that shows that PACK-CXL is an effective corneal infection therapy.
PACK-CXL as adjuvant therapy improves outcomes
“PACK-CXL is safe for use in bacterial keratitis cases. It also seems to add value in reducing healing time and improving final visual acuity while reducing the need for tectonic keratoplasty” noted the study authors.
What’s the best way to cross-link the eyes of wheelchair users?
It can be challenging to cross-link the eyes of wheelchair users – for the patient and clinic staff alike. One
What is the future of CXL?
Corneal cross-linking (CXL) has been used in the clinic for over 20 years now, but if you ever wanted to
More posts:
VIDEOS
Webinars and congresses
Upcoming Event
Januar 21, 2022
NUHS 36th Anniversary Conference

Location: Singapore
Language: English
Upcoming Event
Januar 15, 2022
Muscat International Ophthalmology Conference (MIOC)

Location: Muscat, Oman
Language: English
Upcoming Event
Dezember 4, 2021
Kölner Adventssymposium 2021

Location: Köln, Germany
Language: German
Upcoming Event
November 25, 2021
Middle East Africa Council of Ophthalmology

Location: Dubai, UAE
Language: English
Upcoming Event
November 18, 2021
14th World Down Syndrome Congress

Location: Dubai, UAE
Language: English
Upcoming Event
November 11, 2021
La Société Marocaine de la chirurgie réfractive

Location: Rabat, Morocco
Language: French
Upcoming Event
November 4, 2021
Sorocaba Eye Bank

Location: Brasilien
Language: English
Upcoming Event
Oktober 28, 2021
Emirates Society Of Ophthalmology

Location: Dubai, UAE
Language: English
Upcoming Event
Oktober 23, 2021
LV Prasad Eye Institute

Location: Hyderabad, India
Language: English
Upcoming Event
Oktober 23, 2021
65th Brazilian Congress of Ophthalmology

Location: Natal, Brazil
Language: English